Standout Papers

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modificatio... 2004 2026 2011 2018 1.7k
  1. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA (2005)
    Katalin Karikó, Michael Buckstein et al. Immunity
  2. mRNA-based therapeutics — developing a new class of drugs (2014)
    Uğur Şahin, Katalin Karikó et al. Nature Reviews Drug Discovery
  3. Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability (2008)
    Katalin Karikó, Hiromi Muramatsu et al. Molecular Therapy
  4. mRNA Is an Endogenous Ligand for Toll-like Receptor 3 (2004)
    Katalin Karikó, Houping Ni et al. Journal of Biological Chemistry
  5. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes (2015)
    Norbert Pardi, Steven Tuyishime et al. Journal of Controlled Release
  6. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA (2011)
    Katalin Karikó, Hiromi Muramatsu et al. Nucleic Acids Research
  7. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation (2010)
    Bart R. Anderson, Hiromi Muramatsu et al. Nucleic Acids Research
  8. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA (2019)
    Markus Baiersdörfer, Gábor Boros et al. Molecular Therapy — Nucleic Acids
  9. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis (2021)
    LAURA D. KOLB, Thomas Bukur et al. Science
  10. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge (2017)
    Norbert Pardi, Anthony Secreto et al. Nature Communications
  11. Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin (2012)
    Katalin Karikó, Hiromi Muramatsu et al. Molecular Therapy
  12. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies (2018)
    Norbert Pardi, Kaela Parkhouse et al. Nature Communications
  13. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies (2017)
    Christiane Stadler, Hayat Bähr-Mahmud et al. Nature Medicine
  14. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine (2022)
    Hiromi Muramatsu, Kieu Lam et al. Molecular Therapy
  15. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice (2023)
    Jamile Ramos da Silva, Hiromi Muramatsu et al. Science Translational Medicine

Immediate Impact

34 by Nobel laureates 19 from Science/Nature 155 standout
Sub-graph 1 of 19

Citing Papers

Endosomal escape: A bottleneck for LNP-mediated therapeutics
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout

Works of Katalin Karikó being referenced

mRNA-based therapeutics — developing a new class of drugs
2014 Standout
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
2008 StandoutNobel

Author Peers

Author Last Decade Papers Cites
Katalin Karikó 8787 4036 1290 2181 91 12.6k
Hongkui Deng 8308 3401 595 3022 167 15.7k
Ying K. Tam 6190 2427 505 1714 105 8.7k
Ara G. Hovanessian 8201 5424 849 1585 204 13.4k
Michael B. Mathews 12836 2428 1076 1591 192 17.1k
Rongguang Zhang 5496 2267 482 1387 159 10.3k
Sara Cherry 6561 4246 1663 2458 121 14.0k
Mariano A. García-Blanco 8348 1420 1378 2382 193 13.1k
Marshall S. Horwitz 6895 2918 1053 1638 217 13.4k
Irvin S. Y. Chen 4951 5581 489 3070 176 14.6k
A.J. van der Eb 11763 2458 1135 1442 139 18.0k

All Works

Loading papers...

Rankless by CCL
2026